title: [Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics].
authors: Gaëlle
authors: G
authors: Montmayeur
authors: Emilie
authors: E
authors: Thivat
authors: Pierre
authors: P
authors: Gimbergues
authors: Malek
authors: M
authors: Dib
authors: Marianne
authors: M
authors: Leheurteur
authors: Hervé
authors: H
authors: Curé
authors: Philippe
authors: P
authors: Chollet
authors: Xavier
authors: X
authors: Durando
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D010537:Peritoneum; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017741:Survivors; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D005100:Expectorants; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin